Analgesic Efficacy of Pulsed Radiofrequency in Non-cyclic Mastalgia
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Background: Breast pain, mastalgia or mastodynia, is recognized as an organic benign breast
disease. Mastalgia may be bilateral, may be in only one breast or part of one breast, and may
radiate to the axilla and down the medial aspect of the upper arm. This study aimed to
evaluate the additional pulsed radiofrequency of 2nd , 3rd and 4th thoracic dorsal root
ganglia to the routine regimen treatment of mastalgia tamoxifen 10 mg daily may improve
breast pain severity and quality of life.
Method: Patients was randomly classified into two groups:Group A (n=13): they was received
Tamoxifen 10 mg daily. Group B (n=13): they was received Tamoxifen 10 mg daily and pulsed
radiofrequency of 2nd , 3rd and 4th thoracic dorsal root ganglia. The following parameters
were monitored: Primary outcome: VAS after injection and at interval two weeks, 1, 2 and 3
months after injection. Secondary outcome:1-Immediate complications for ex. Hematoma,
neurological deficits or respiratory insufficiency (dyspnea or pneumothorax).2-Need for
analgesic intake was recorded.3-Side effect of Tamoxifen as nausea, vomiting, hot flashes and
dizziness.4-Quality of life (The American Chronic Pain Association's Quality of life scale).